PharmaCyte Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ayrton Capital LLC(9.9%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.9%), etc.
Feb 14 15:45 ET
PharmaCyte Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%), etc.
Feb 6 10:01 ET
PharmaCyte Biotech | 3: Initial statement of beneficial ownership of securities-10% Owner PharmaCyte Biotech, Inc.
Nov 28, 2023 17:06 ET
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director WEINSTEIN ROBERT
Nov 22, 2023 17:02 ET
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director WALKER WAYNE REMELL
Nov 22, 2023 17:02 ET
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Trujillo Carlos
Nov 22, 2023 17:01 ET
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Silverman Joshua
Nov 22, 2023 17:01 ET
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director SCHECHTER JONATHAN
Nov 22, 2023 17:01 ET
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities-Director Abecassis Michael M
Nov 22, 2023 17:00 ET
PharmaCyte Biotech | SC 13D: Statement of acquisition of beneficial ownership by individuals-PharmaCyte Biotech, Inc.(37.0%)
Nov 22, 2023 16:00 ET
PharmaCyte Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Iroquois Master Fund Ltd.(4.99%),Iroquois Capital Management, LLC(4.99%), etc.
Jun 16, 2023 17:22 ET
PharmaCyte Biotech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Ayrton Capital LLC(9.99%),Alto Opportunity Master Fund, SPC – Segregated Master Portfolio B(9.99%), etc.
May 19, 2023 17:19 ET
PharmaCyte Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Abbe(7.0%),Iroquois Master Fund Ltd.(6.6%), etc.
May 12, 2023 16:22 ET
PharmaCyte Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Shay Capital LLC(0.00%),Shay Capital Holdings LLC(0.00%)
Feb 14, 2023 16:30 ET
PharmaCyte Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Daniel B. Asher(9.99%),Mitchell P. Kopin(8.4%), etc.
Feb 8, 2023 06:05 ET
PharmaCyte Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Jan 10, 2023 11:57 ET
PharmaCyte Biotech | 3: Initial statement of beneficial ownership of securities-Director WALKER WAYNE REMELL
Dec 30, 2022 16:06 ET
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities
Dec 30, 2022 16:05 ET
PharmaCyte Biotech | 4: Statement of changes in beneficial ownership of securities
Dec 30, 2022 16:05 ET
PharmaCyte Biotech | 3: Initial statement of beneficial ownership of securities-Director WEINSTEIN ROBERT
Nov 16, 2022 16:12 ET
No Data
No Data